Upregulation of the amyloid-degrading enzyme, neprilysin, results in decreased amyloid and apoptosis in islets from human islet amyloid polypeptide (hIAPP) transgenic mice

---

Autoria(s): Zraika, Sakeneh; Aston-Mourney, Kathryn; Hull, Rebecca L.; Udayasankar, Jayalakshmi; Subramanian, Shoba L.; Green, Pattie S.; Kahn, Steven E.

Contribuinte(s)	[Unknown]
Data(s)	01/01/2009
Identificador	http://hdl.handle.net/10536/DRO/DU:30049281
Idioma(s)	eng
Publicador	American Diabetes Association
Relação	http://dro.deakin.edu.au/eserv/DU:30049281/zraika-upregulationof-2009.pdf
Palavras-Chave	#Diabetes #Neprilysin #Alzheimer's disease
Tipo	Conference Paper